These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 224984)

  • 1. An approach to measuring the in vivo transformation of glycerol to a very low density lipoprotein triglyceride.
    Kallai-Sanfaçon MA; Norwich KH; Steiner G
    Can J Biochem; 1979 Jun; 57(6):613-7. PubMed ID: 224984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of VLDL triglyceride production by the liver and intestine.
    Steiner G; Ilse WK
    Can J Biochem; 1981 Aug; 59(8):637-41. PubMed ID: 7296346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VLDL-triglyceride production after alcohol ingestion, studied using [2-13C1] glycerol.
    Siler SQ; Neese RA; Parks EJ; Hellerstein MK
    J Lipid Res; 1998 Dec; 39(12):2319-28. PubMed ID: 9831620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nicotinic acid administration on hepatic very low density lipoprotein-triglyceride production.
    Wang W; Basinger A; Neese RA; Shane B; Myong SA; Christiansen M; Hellerstein MK
    Am J Physiol Endocrinol Metab; 2001 Mar; 280(3):E540-7. PubMed ID: 11171611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular triglyceride synthesis and transfer to lipid droplets and nascent very low density lipoproteins.
    Chao FF; Stiers DL; Ontko JA
    J Lipid Res; 1986 Nov; 27(11):1174-81. PubMed ID: 3559383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes.
    Durrington PN; Newton RS; Weinstein DB; Steinberg D
    J Clin Invest; 1982 Jul; 70(1):63-73. PubMed ID: 7045162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sources of blood glycerol during fasting.
    Jensen MD; Chandramouli V; Schumann WC; Ekberg K; Previs SF; Gupta S; Landau BR
    Am J Physiol Endocrinol Metab; 2001 Nov; 281(5):E998-1004. PubMed ID: 11595656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimates of hepatic glyceroneogenesis in type 2 diabetes mellitus in humans.
    Kalhan SC; Bugianesi E; McCullough AJ; Hanson RW; Kelley DE
    Metabolism; 2008 Mar; 57(3):305-12. PubMed ID: 18249200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring very low density lipoprotein-triglyceride kinetics in man in vivo: how different the various methods really are.
    Magkos F; Sidossis LS
    Curr Opin Clin Nutr Metab Care; 2004 Sep; 7(5):547-55. PubMed ID: 15295275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous triglyceride turnover in liver and plasma of the dog.
    Gross RC; Eigenbrodt EH; Farquhar JW
    J Lipid Res; 1967 Mar; 8(2):114-25. PubMed ID: 14564717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lovastatin therapy on very-low-density lipoprotein triglyceride metabolism in subjects with combined hyperlipidemia: evidence for reduced assembly and secretion of triglyceride-rich lipoproteins.
    Arad Y; Ramakrishnan R; Ginsberg HN
    Metabolism; 1992 May; 41(5):487-93. PubMed ID: 1588827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Turnover of plasma total and very low density lipoprotein triglyceride in man.
    Kekki M; Nikkilä EA
    Scand J Clin Lab Invest; 1975 Mar; 35(2):171-9. PubMed ID: 167428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression by diets rich in fish oil of very low density lipoprotein production in man.
    Nestel PJ; Connor WE; Reardon MF; Connor S; Wong S; Boston R
    J Clin Invest; 1984 Jul; 74(1):82-9. PubMed ID: 6736254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with artificial beta-cell decreases very-low-density lipoprotein triglyceride synthesis in type I diabetes.
    Dunn FL; Carroll PB; Beltz WF
    Diabetes; 1987 May; 36(5):661-6. PubMed ID: 3552799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein cholesterol and triglyceride concentrations associated with dog body condition score; effect of recommended fasting duration on sample concentrations in Japanese private clinics.
    Usui S; Yasuda H; Koketsu Y
    J Vet Med Sci; 2015 Sep; 77(9):1063-9. PubMed ID: 25866404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic model for production and metabolism of very low density lipoprotein triglycerides. Evidence for a slow production pathway and results for normolipidemic subjects.
    Zech LA; Grundy SM; Steinberg D; Berman M
    J Clin Invest; 1979 Jun; 63(6):1262-73. PubMed ID: 221537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic effects of Troglitazone in patients with diet-controlled type 2 diabetes.
    Robinson AC; Jeffs JA; Gray RG; Bannister PA; Mather H; Gallagher JJ; Robinson S; Nattrass M; Venkatesan S; Halliday D; Johnston DG
    Eur J Clin Invest; 2004 Jan; 34(1):29-36. PubMed ID: 14984435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypotriglyceridemic effects of levonorgestrel in rats.
    Khokha R; Wolfe BM
    Atherosclerosis; 1984 Sep; 52(3):329-38. PubMed ID: 6437417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia.
    Kissebah AH; Alfarsi S; Adams PW
    Metabolism; 1981 Sep; 30(9):856-68. PubMed ID: 7266376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.